The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Carboquone Therapy for Hematologic Neoplasms
YOSHIRO UZUKA, YOSHIKO SAITO, HARUHIKO TAKAHASHI, MART KOMATSU
著者情報
キーワード: Carboquone, malignant lymphoma, multiple myeloma, chronic myelogenous leukemia
ジャーナル フリー

1982 年 138 巻 2 号 p. 151-160

詳細
PDFをダウンロード (764K)
メタデータをダウンロード RIS形式

(EndNote、Reference Manager、ProCite、RefWorksとの互換性あり)

BIB TEX形式

(BibDesk、LaTeXとの互換性あり)

テキスト
メタデータのダウンロード方法
発行機関連絡先
抄録
UZUKA, Y., SAITO, Y., TAKAHASHI, H. and KOMATSU, M. Carboquone Therapy for Hematologic Neoplasms. Tohoku J. exp. Med., 1982, 138 (2), 151-160-A daily oral dose of 1-2mg of Carboquone was administered for remission induction to 38 patients with hematologic malignancy, and the following results were obtained: 2 of the 3 patients with malignant lymphoma, 1 of the 12 patients with multiple myeloma, 13 of the 14 patients with chronic myelogenous leukemia, and all 9 patients with polycythemia very attained complete remission.
著者関連情報
© Tohoku University Medical Press
前の記事 次の記事
お気に入り & アラート

閲覧履歴
  • About this Journal
    The Tohoku Journal of Experimental Medicine (TJEM) was founded in 1920 by professors of Tohoku Imperial University, Medical School. The TJEM has been published continuously, except for the year of 1946 just after the World War II. The TJEM is open to original articles in all branches of medical sciences. The TJEM also covers the fields of disaster-prevention science, including earthquake archeology.


  • Submitted manuscripts will be screened for plagiarism with Similarity Check (https://www.crossref.org/services/similarity-check/).
発行機関からのお知らせ
  • Subscriptions
    Inland subscriptions should be sent to Tohoku University Medical Press, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, JAPAN.

    Subscriptions from abroad should be addressed to MARUZEN CO., LTD., EXPORT DEPARTMENT, Postal address: P.O.Box 75, Shinagawa, Tokyo 140-8799, JAPAN. 
    e-mail: export@maruzen.co.jp

このページを共有する
feedback
 Top